neil-buddy-shah-ed5f7df2·3 events·first seen Aliases: Neil 'Buddy' Shah, Neil Buddy Shah
Anthropic's Long-Term Benefit Trust (LTBT) has appointed Ben Bernanke, former Federal Reserve Chair and 2022 Nobel laureate in Economics, as its newest member. The LTBT is an independent governance body that holds Anthropic accountable to its mission of responsible AI development and has authority to appoint members to Anthropic's board. Bernanke's appointment is framed around his expertise in economic disruption and crisis management, with Anthropic citing his relevance to understanding AI's macroeconomic effects. The move signals Anthropic's continued investment in its distinctive governance structure as a Public Benefit Corporation.
Anthropic's Long-Term Benefit Trust has appointed Mariano-Florentino (Tino) Cuéllar, a former California Supreme Court Justice and current Carnegie Endowment for International Peace president, as a new member. Cuéllar brings expertise in law, governance, and international affairs, including co-leading California's Working Group on AI Frontier Models alongside Fei-Fei Li. The announcement also notes the departure of founding trustees Kanika Bahl and Zachary Robinson, who helped establish the Trust's governance role since 2023. The LTBT is an independent body with no financial stake in Anthropic that selects board members and advises on maximizing AI benefits while mitigating risks.
Anthropic's Long-Term Benefit Trust has appointed Vas Narasimhan, CEO of Novartis and physician-scientist, to Anthropic's Board of Directors. The appointment means Trust-appointed directors now constitute a majority of the Board, reinforcing the governance structure designed to balance commercial interests with Anthropic's public benefit mission. Narasimhan brings experience overseeing regulatory approval of over 35 novel medicines and is expected to contribute perspective on deploying powerful technology safely at scale, particularly in healthcare and life sciences.